Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain

Recently, nanocarriers that transport bioactive substances to a target site in the body have attracted considerable attention and undergone rapid progression in terms of the state of the art. However, few nanocarriers can enter the brain via a systemic route through the blood-brain barrier (BBB) to...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 8; no. 1; pp. 1001 - 9
Main Authors Anraku, Y., Kuwahara, H., Fukusato, Y., Mizoguchi, A., Ishii, T., Nitta, K., Matsumoto, Y., Toh, K., Miyata, K., Uchida, S., Nishina, K., Osada, K., Itaka, K., Nishiyama, N., Mizusawa, H., Yamasoba, T., Yokota, T., Kataoka, K.
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 17.10.2017
Nature Publishing Group
Nature Portfolio
Subjects
Online AccessGet full text
ISSN2041-1723
2041-1723
DOI10.1038/s41467-017-00952-3

Cover

Abstract Recently, nanocarriers that transport bioactive substances to a target site in the body have attracted considerable attention and undergone rapid progression in terms of the state of the art. However, few nanocarriers can enter the brain via a systemic route through the blood-brain barrier (BBB) to efficiently reach neurons. Here we prepare a self-assembled supramolecular nanocarrier with a surface featuring properly configured glucose. The BBB crossing and brain accumulation of this nanocarrier are boosted by the rapid glycaemic increase after fasting and by the putative phenomenon of the highly expressed glucose transporter-1 (GLUT1) in brain capillary endothelial cells migrating from the luminal to the abluminal plasma membrane. The precisely controlled glucose density on the surface of the nanocarrier enables the regulation of its distribution within the brain, and thus is successfully optimized to increase the number of nanocarriers accumulating in neurons. There are only a few examples of nanocarriers that can transport bioactive substances across the blood-brain barrier. Here the authors show that by rapid glycaemic increase the accumulation of a glucosylated nanocarrier in the brain can be controlled.
AbstractList There are only a few examples of nanocarriers that can transport bioactive substances across the blood-brain barrier. Here the authors show that by rapid glycaemic increase the accumulation of a glucosylated nanocarrier in the brain can be controlled.
Recently, nanocarriers that transport bioactive substances to a target site in the body have attracted considerable attention and undergone rapid progression in terms of the state of the art. However, few nanocarriers can enter the brain via a systemic route through the blood-brain barrier (BBB) to efficiently reach neurons. Here we prepare a self-assembled supramolecular nanocarrier with a surface featuring properly configured glucose. The BBB crossing and brain accumulation of this nanocarrier are boosted by the rapid glycaemic increase after fasting and by the putative phenomenon of the highly expressed glucose transporter-1 (GLUT1) in brain capillary endothelial cells migrating from the luminal to the abluminal plasma membrane. The precisely controlled glucose density on the surface of the nanocarrier enables the regulation of its distribution within the brain, and thus is successfully optimized to increase the number of nanocarriers accumulating in neurons.There are only a few examples of nanocarriers that can transport bioactive substances across the blood-brain barrier. Here the authors show that by rapid glycaemic increase the accumulation of a glucosylated nanocarrier in the brain can be controlled.
Recently, nanocarriers that transport bioactive substances to a target site in the body have attracted considerable attention and undergone rapid progression in terms of the state of the art. However, few nanocarriers can enter the brain via a systemic route through the blood-brain barrier (BBB) to efficiently reach neurons. Here we prepare a self-assembled supramolecular nanocarrier with a surface featuring properly configured glucose. The BBB crossing and brain accumulation of this nanocarrier are boosted by the rapid glycaemic increase after fasting and by the putative phenomenon of the highly expressed glucose transporter-1 (GLUT1) in brain capillary endothelial cells migrating from the luminal to the abluminal plasma membrane. The precisely controlled glucose density on the surface of the nanocarrier enables the regulation of its distribution within the brain, and thus is successfully optimized to increase the number of nanocarriers accumulating in neurons.
Recently, nanocarriers that transport bioactive substances to a target site in the body have attracted considerable attention and undergone rapid progression in terms of the state of the art. However, few nanocarriers can enter the brain via a systemic route through the blood-brain barrier (BBB) to efficiently reach neurons. Here we prepare a self-assembled supramolecular nanocarrier with a surface featuring properly configured glucose. The BBB crossing and brain accumulation of this nanocarrier are boosted by the rapid glycaemic increase after fasting and by the putative phenomenon of the highly expressed glucose transporter-1 (GLUT1) in brain capillary endothelial cells migrating from the luminal to the abluminal plasma membrane. The precisely controlled glucose density on the surface of the nanocarrier enables the regulation of its distribution within the brain, and thus is successfully optimized to increase the number of nanocarriers accumulating in neurons.There are only a few examples of nanocarriers that can transport bioactive substances across the blood-brain barrier. Here the authors show that by rapid glycaemic increase the accumulation of a glucosylated nanocarrier in the brain can be controlled.Recently, nanocarriers that transport bioactive substances to a target site in the body have attracted considerable attention and undergone rapid progression in terms of the state of the art. However, few nanocarriers can enter the brain via a systemic route through the blood-brain barrier (BBB) to efficiently reach neurons. Here we prepare a self-assembled supramolecular nanocarrier with a surface featuring properly configured glucose. The BBB crossing and brain accumulation of this nanocarrier are boosted by the rapid glycaemic increase after fasting and by the putative phenomenon of the highly expressed glucose transporter-1 (GLUT1) in brain capillary endothelial cells migrating from the luminal to the abluminal plasma membrane. The precisely controlled glucose density on the surface of the nanocarrier enables the regulation of its distribution within the brain, and thus is successfully optimized to increase the number of nanocarriers accumulating in neurons.There are only a few examples of nanocarriers that can transport bioactive substances across the blood-brain barrier. Here the authors show that by rapid glycaemic increase the accumulation of a glucosylated nanocarrier in the brain can be controlled.
Recently, nanocarriers that transport bioactive substances to a target site in the body have attracted considerable attention and undergone rapid progression in terms of the state of the art. However, few nanocarriers can enter the brain via a systemic route through the blood-brain barrier (BBB) to efficiently reach neurons. Here we prepare a self-assembled supramolecular nanocarrier with a surface featuring properly configured glucose. The BBB crossing and brain accumulation of this nanocarrier are boosted by the rapid glycaemic increase after fasting and by the putative phenomenon of the highly expressed glucose transporter-1 (GLUT1) in brain capillary endothelial cells migrating from the luminal to the abluminal plasma membrane. The precisely controlled glucose density on the surface of the nanocarrier enables the regulation of its distribution within the brain, and thus is successfully optimized to increase the number of nanocarriers accumulating in neurons. There are only a few examples of nanocarriers that can transport bioactive substances across the blood-brain barrier. Here the authors show that by rapid glycaemic increase the accumulation of a glucosylated nanocarrier in the brain can be controlled.
ArticleNumber 1001
Author Osada, K.
Anraku, Y.
Toh, K.
Kataoka, K.
Uchida, S.
Itaka, K.
Nishiyama, N.
Mizusawa, H.
Mizoguchi, A.
Fukusato, Y.
Yokota, T.
Ishii, T.
Nishina, K.
Nitta, K.
Miyata, K.
Kuwahara, H.
Yamasoba, T.
Matsumoto, Y.
Author_xml – sequence: 1
  givenname: Y.
  surname: Anraku
  fullname: Anraku, Y.
  organization: Department of Bioengineering, Graduate School of Engineering, The University of Tokyo
– sequence: 2
  givenname: H.
  surname: Kuwahara
  fullname: Kuwahara, H.
  organization: Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Center for Brain Integration Research, Tokyo Medical and Dental University (TMDU)
– sequence: 3
  givenname: Y.
  surname: Fukusato
  fullname: Fukusato, Y.
  organization: Department of Bioengineering, Graduate School of Engineering, The University of Tokyo
– sequence: 4
  givenname: A.
  surname: Mizoguchi
  fullname: Mizoguchi, A.
  organization: Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo
– sequence: 5
  givenname: T.
  surname: Ishii
  fullname: Ishii, T.
  organization: Department of Bioengineering, Graduate School of Engineering, The University of Tokyo
– sequence: 6
  givenname: K.
  surname: Nitta
  fullname: Nitta, K.
  organization: Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Center for Brain Integration Research, Tokyo Medical and Dental University (TMDU)
– sequence: 7
  givenname: Y.
  orcidid: 0000-0002-0530-1326
  surname: Matsumoto
  fullname: Matsumoto, Y.
  organization: Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Department of Otorhinolaryngology and Head and Neck Surgery, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo
– sequence: 8
  givenname: K.
  surname: Toh
  fullname: Toh, K.
  organization: Innovation Center of NanoMedicine, Kawasaki Institute of Industrial Promotion
– sequence: 9
  givenname: K.
  surname: Miyata
  fullname: Miyata, K.
  organization: Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Department of Materials Engineering, Graduate School of Engineering, The University of Tokyo
– sequence: 10
  givenname: S.
  surname: Uchida
  fullname: Uchida, S.
  organization: Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo
– sequence: 11
  givenname: K.
  surname: Nishina
  fullname: Nishina, K.
  organization: Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Center for Brain Integration Research, Tokyo Medical and Dental University (TMDU)
– sequence: 12
  givenname: K.
  surname: Osada
  fullname: Osada, K.
  organization: Department of Bioengineering, Graduate School of Engineering, The University of Tokyo
– sequence: 13
  givenname: K.
  surname: Itaka
  fullname: Itaka, K.
  organization: Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo
– sequence: 14
  givenname: N.
  surname: Nishiyama
  fullname: Nishiyama, N.
  organization: Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology
– sequence: 15
  givenname: H.
  surname: Mizusawa
  fullname: Mizusawa, H.
  organization: Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Center for Brain Integration Research, Tokyo Medical and Dental University (TMDU)
– sequence: 16
  givenname: T.
  surname: Yamasoba
  fullname: Yamasoba, T.
  organization: Department of Otorhinolaryngology and Head and Neck Surgery, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo
– sequence: 17
  givenname: T.
  surname: Yokota
  fullname: Yokota, T.
  email: tak-yokota.nuro@tmd.ac.jp
  organization: Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Center for Brain Integration Research, Tokyo Medical and Dental University (TMDU)
– sequence: 18
  givenname: K.
  surname: Kataoka
  fullname: Kataoka, K.
  email: kataoka@bmw.t.u-tokyo.ac.jp
  organization: Innovation Center of NanoMedicine, Kawasaki Institute of Industrial Promotion, Policy Alternatives Research Institute, The University of Tokyo
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29042554$$D View this record in MEDLINE/PubMed
BookMark eNp9Ul1rFDEUDVKxtfYP-CADvvgymo-bmcmL4BathYII-hwymcw0SzapSUbYf292ppZtQQMhX-ecXO45L9GJD94g9Jrg9wSz7kMCAk1bY1ImFpzW7Bk6oxhITVrKTo72p-gipS0ugwnSAbxAp1RgoJzDGfp-5fZamZ3VlQ4-x-CqPoSUUzW5WYe0dyqbofLKB61itCZWOoaUrJ-qfGuqzWZTWZ_Dcuijsv4Vej4ql8zF_XqOfn75_OPya33z7er68tNNrXkHuebc9HxsgDQDGxthhlHgTmtgFIAIA0xBK8Soup43rR7wAJoIANEDa6nChJ2j61V3CGor76LdqbiXQVm5XIQ4SRWz1c5IPGoCbBh1Cw1oajrMDGWi74qo7oEWrY-r1t3c78ygTemEco9EH794eyun8FvyBjjrRBF4dy8Qw6_ZpCx3NmnjnPImzEmS4hCnoqFQoG-fQLdhjr60akGRhrbigHpzXNFDKX-dKwC6AhY7ohkfIATLQ0LkmhBZEiKXhEhWSN0TkrZZZXtwXln3fypbqan84ycTj8r-N-sPfODOzg
CitedBy_id crossref_primary_10_1002_tox_24259
crossref_primary_10_1016_j_jconrel_2023_10_019
crossref_primary_10_1248_cpb_c20_00041
crossref_primary_10_1016_j_addr_2020_06_007
crossref_primary_10_1021_acs_biomac_8b01406
crossref_primary_10_1038_s41578_024_00695_w
crossref_primary_10_1002_pep2_24392
crossref_primary_10_1039_C8CS00805A
crossref_primary_10_1016_j_addr_2023_115073
crossref_primary_10_2147_IJN_S457393
crossref_primary_10_1039_D3NA01125A
crossref_primary_10_1080_17425247_2023_2255138
crossref_primary_10_1021_acs_bioconjchem_2c00389
crossref_primary_10_1007_s12088_024_01330_6
crossref_primary_10_1002_advs_202003937
crossref_primary_10_3389_fimmu_2023_1241791
crossref_primary_10_1016_j_cis_2023_103008
crossref_primary_10_1021_acsnano_4c05906
crossref_primary_10_1021_acs_molpharmaceut_9b00691
crossref_primary_10_1039_D0RA10392F
crossref_primary_10_3390_pharmaceutics13071003
crossref_primary_10_1021_acs_biomac_0c01661
crossref_primary_10_1007_s10853_019_04079_2
crossref_primary_10_1039_D4ME00105B
crossref_primary_10_1021_acs_chemrev_0c01338
crossref_primary_10_1021_acs_macromol_0c02031
crossref_primary_10_1021_acsnano_3c09715
crossref_primary_10_1016_j_lfs_2021_119129
crossref_primary_10_1021_acs_nanolett_3c00377
crossref_primary_10_1021_acs_bioconjchem_4c00555
crossref_primary_10_2745_dds_33_335
crossref_primary_10_1021_acsmacrolett_8b00812
crossref_primary_10_1002_adfm_202312595
crossref_primary_10_1126_sciadv_abm7077
crossref_primary_10_1016_j_addr_2022_114480
crossref_primary_10_1021_acs_nanolett_3c04175
crossref_primary_10_1016_j_addr_2020_10_001
crossref_primary_10_1080_17425247_2023_2245332
crossref_primary_10_1073_pnas_2002016117
crossref_primary_10_1186_s12951_023_02022_x
crossref_primary_10_1039_D4MH00325J
crossref_primary_10_3390_molecules28237750
crossref_primary_10_1080_1061186X_2021_1904250
crossref_primary_10_70401_bmeh_2024_124
crossref_primary_10_1007_s44258_023_00004_0
crossref_primary_10_1093_jmicro_dfac005
crossref_primary_10_1016_j_biomaterials_2022_121640
crossref_primary_10_3389_fnins_2023_1137096
crossref_primary_10_1002_adhm_202202688
crossref_primary_10_1016_j_mtchem_2022_101104
crossref_primary_10_1039_C9TB00860H
crossref_primary_10_1186_s12987_023_00466_9
crossref_primary_10_1016_j_tibtech_2018_01_006
crossref_primary_10_3390_ijms241612541
crossref_primary_10_14336_AD_2022_0130_1
crossref_primary_10_3390_pharmaceutics13122045
crossref_primary_10_1126_sciadv_abc4397
crossref_primary_10_1186_s12987_020_00209_0
crossref_primary_10_1002_anie_201914751
crossref_primary_10_1515_ntrev_2022_0548
crossref_primary_10_3233_JAD_230098
crossref_primary_10_1002_adma_202301099
crossref_primary_10_1212_WNL_90_15_supplement_S5_008
crossref_primary_10_1038_s41551_021_00803_z
crossref_primary_10_1007_s11095_022_03385_w
crossref_primary_10_3390_cancers12102837
crossref_primary_10_1016_j_carbpol_2024_123207
crossref_primary_10_1016_j_addr_2022_114619
crossref_primary_10_3390_pharmaceutics12060579
crossref_primary_10_3389_fddev_2024_1360302
crossref_primary_10_1016_j_jconrel_2023_12_001
crossref_primary_10_32604_or_2024_047278
crossref_primary_10_1039_D1CS00574J
crossref_primary_10_1002_adtp_202200001
crossref_primary_10_1016_j_mtadv_2023_100341
crossref_primary_10_1002_advs_202101090
crossref_primary_10_3390_pharmaceutics14061283
crossref_primary_10_1002_mabi_202000049
crossref_primary_10_2745_dds_33_377
crossref_primary_10_1002_smll_202300403
crossref_primary_10_3390_pharmaceutics13122024
crossref_primary_10_1186_s12951_023_01772_y
crossref_primary_10_1002_adfm_201910369
crossref_primary_10_1016_j_jddst_2023_105267
crossref_primary_10_1016_j_mtbio_2021_100167
crossref_primary_10_1002_advs_202103148
crossref_primary_10_1002_advs_202004929
crossref_primary_10_1021_acscentsci_9b00843
crossref_primary_10_1021_acs_nanolett_4c03672
crossref_primary_10_1016_j_biomaterials_2019_119491
crossref_primary_10_3389_fnins_2022_939855
crossref_primary_10_1002_adhm_202100801
crossref_primary_10_1021_acsnano_1c08689
crossref_primary_10_4155_tde_2022_0035
crossref_primary_10_1002_asia_201701542
crossref_primary_10_1002_wnan_1898
crossref_primary_10_1016_j_mattod_2020_02_001
crossref_primary_10_1038_s41467_019_12554_2
crossref_primary_10_1038_s41573_021_00139_y
crossref_primary_10_26508_lsa_202101193
crossref_primary_10_1016_j_jconrel_2022_04_013
crossref_primary_10_3390_cancers16193300
crossref_primary_10_1016_j_ejcb_2024_151406
crossref_primary_10_1080_17425247_2019_1583205
crossref_primary_10_1038_s44222_023_00138_1
crossref_primary_10_1021_acs_molpharmaceut_1c00297
crossref_primary_10_1016_j_bcp_2018_07_008
crossref_primary_10_1016_j_addr_2021_114029
crossref_primary_10_1021_acs_biomac_4c01052
crossref_primary_10_1021_jacs_0c09029
crossref_primary_10_1039_D1BM01506K
crossref_primary_10_1016_j_apsb_2020_11_023
crossref_primary_10_1021_acs_chemrev_3c00705
crossref_primary_10_1021_acs_accounts_3c00151
crossref_primary_10_1021_acs_molpharmaceut_1c00856
crossref_primary_10_1016_j_biomaterials_2025_123138
crossref_primary_10_3390_biomedicines12092135
crossref_primary_10_1002_adtp_202300161
crossref_primary_10_1016_j_omtn_2023_102065
crossref_primary_10_1016_j_addr_2021_02_007
crossref_primary_10_1016_j_actbio_2025_01_016
crossref_primary_10_3390_pharmaceutics12121216
crossref_primary_10_3390_molecules28031151
crossref_primary_10_3390_nano12122072
crossref_primary_10_3389_fbioe_2023_1177151
crossref_primary_10_1002_jgm_3091
crossref_primary_10_1016_j_jconrel_2025_113595
crossref_primary_10_3390_ijms23020760
crossref_primary_10_1021_acs_molpharmaceut_7b01084
crossref_primary_10_1002_adfm_202200016
crossref_primary_10_1186_s12951_024_02940_4
crossref_primary_10_1080_17425247_2022_2139369
crossref_primary_10_1016_j_ajps_2020_07_001
crossref_primary_10_1002_ange_201914751
crossref_primary_10_1016_j_neurobiolaging_2018_05_010
crossref_primary_10_1016_j_biopha_2023_115174
crossref_primary_10_1016_j_copbio_2024_103108
crossref_primary_10_1016_j_addr_2021_113999
crossref_primary_10_1021_jacs_3c05638
crossref_primary_10_1016_j_fmre_2022_03_003
crossref_primary_10_3389_fonc_2024_1441460
crossref_primary_10_1016_j_jconrel_2018_04_034
crossref_primary_10_1021_acs_jafc_4c08452
crossref_primary_10_3390_pharmaceutics14061240
crossref_primary_10_1021_jacs_2c04418
crossref_primary_10_1038_s41598_018_22577_2
crossref_primary_10_1186_s40580_018_0168_8
crossref_primary_10_1039_C9BM01750J
crossref_primary_10_1016_j_actbio_2021_12_003
crossref_primary_10_1021_jacs_4c02463
crossref_primary_10_1016_j_ccr_2022_214785
crossref_primary_10_1021_acs_langmuir_1c02390
crossref_primary_10_3390_ijms23084153
crossref_primary_10_1007_s13346_021_01008_2
crossref_primary_10_1016_j_ejmech_2025_117357
crossref_primary_10_1016_j_biomaterials_2024_122537
crossref_primary_10_1016_j_omtn_2024_102340
crossref_primary_10_1021_acsami_4c15671
crossref_primary_10_3389_fphar_2024_1333006
crossref_primary_10_1021_acsnano_9b09991
crossref_primary_10_1021_jacs_3c12502
crossref_primary_10_1016_j_ijpharm_2023_122924
crossref_primary_10_1021_acs_chemrev_8b00199
crossref_primary_10_1039_D2BM01572B
crossref_primary_10_1039_D3NR06154J
crossref_primary_10_1002_ctd2_43
crossref_primary_10_1016_j_biopha_2021_111354
crossref_primary_10_1016_j_jconrel_2019_01_006
crossref_primary_10_1016_j_jconrel_2020_09_043
crossref_primary_10_2217_nnm_2020_0088
crossref_primary_10_1002_adhm_202302902
crossref_primary_10_1016_j_mtnano_2023_100347
crossref_primary_10_3389_fncel_2022_1020644
crossref_primary_10_1016_j_jconrel_2024_05_044
crossref_primary_10_1126_sciadv_abd6889
crossref_primary_10_1016_j_phyplu_2024_100704
crossref_primary_10_3390_pharmaceutics14020361
crossref_primary_10_1016_j_nantod_2021_101239
crossref_primary_10_1016_j_ijbiomac_2025_139532
crossref_primary_10_1126_sciadv_abc7031
crossref_primary_10_1016_j_jconrel_2024_12_066
crossref_primary_10_1016_j_mtbio_2020_100055
crossref_primary_10_1016_j_pharmthera_2023_108527
crossref_primary_10_1002_adma_201902604
crossref_primary_10_1016_j_biomaterials_2019_119752
crossref_primary_10_1073_pnas_1912012117
crossref_primary_10_2217_nnm_2021_0486
crossref_primary_10_1016_j_bmc_2020_115852
crossref_primary_10_1016_j_jcis_2024_05_067
crossref_primary_10_1002_advs_202105854
crossref_primary_10_1016_j_jconrel_2019_02_021
crossref_primary_10_1016_j_jconrel_2020_10_043
crossref_primary_10_1021_acs_macromol_2c00557
crossref_primary_10_1021_acs_biomac_4c00210
crossref_primary_10_3390_pharmaceutics13081193
crossref_primary_10_1016_j_apsb_2022_05_016
crossref_primary_10_1021_acs_biomac_9b01291
crossref_primary_10_1039_D1NA00145K
crossref_primary_10_1021_acsbiomaterials_1c00730
crossref_primary_10_1002_cnma_202200014
crossref_primary_10_1002_adma_202208018
crossref_primary_10_1038_s41598_020_75253_9
crossref_primary_10_1007_s11095_022_03223_z
crossref_primary_10_1016_j_nantod_2022_101556
crossref_primary_10_1021_acsnano_1c00316
crossref_primary_10_3389_fphar_2021_756724
Cites_doi 10.1038/nmat1081
10.2147/IJN.S23771
10.1111/apha.12250
10.1042/bj1310211
10.1364/BOE.1.001209
10.1038/nrd1088
10.1111/j.1600-0854.2009.00894.x
10.1038/nnano.2011.166
10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3
10.1038/nrm2755
10.1111/j.1528-1167.2012.03637.x
10.1016/j.nbd.2009.07.030
10.1021/bi2000356
10.1016/j.biomaterials.2013.09.094
10.1056/NEJMra0912273
10.1529/biophysj.104.047886
10.1073/pnas.1000346107
10.1046/j.1471-4159.1999.0720238.x
10.1016/j.jconrel.2014.06.042
10.1038/nrd2591
10.1038/nrd.2015.21
10.1038/nrm3351
10.1038/nrc1566
10.1038/bjc.2011.6
10.1111/j.1471-4159.2011.07208.x
10.1203/PDR.0b013e31815b440b
10.1038/sj.bjc.6603855
10.1073/pnas.1307152110
10.3109/10611861003587235
10.1038/nrd4363
10.1161/01.STR.14.3.388
10.1038/nnano.2007.70
10.1002/jnr.490220413
10.1016/j.jconrel.2009.03.002
10.1016/S0021-9258(19)85527-8
ContentType Journal Article
Copyright The Author(s) 2017
2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2017
– notice: 2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7T7
7TM
7TO
7X7
7XB
88E
8AO
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
ARAPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7P
P5Z
P62
P64
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
RC3
SOI
7X8
5PM
DOA
DOI 10.1038/s41467-017-00952-3
DatabaseName Springer Nature Link OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Ecology Abstracts
Entomology Abstracts (Full archive)
Environment Abstracts
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
ProQuest - Health & Medical Complete保健、医学与药学数据库
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni)
Medical Database
Biological Science Database
ProQuest advanced technologies & aerospace journals
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Genetics Abstracts
Environment Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
Chemoreception Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Advanced Technologies & Aerospace Collection
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Entomology Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
AIDS and Cancer Research Abstracts
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Immunology Abstracts
Environment Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
Publicly Available Content Database
MEDLINE - Academic
CrossRef


Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2041-1723
EndPage 9
ExternalDocumentID oai_doaj_org_article_0fc143dfc7464c2e803e239b8d4ccb42
PMC5645389
29042554
10_1038_s41467_017_00952_3
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
0R~
39C
3V.
53G
5VS
70F
7X7
88E
8AO
8FE
8FG
8FH
8FI
8FJ
AAHBH
AAJSJ
ABUWG
ACGFO
ACGFS
ACIWK
ACMJI
ACPRK
ACSMW
ADBBV
ADFRT
ADMLS
ADRAZ
AENEX
AEUYN
AFKRA
AFRAH
AHMBA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMTXH
AOIJS
ARAPS
ASPBG
AVWKF
AZFZN
BAPOH
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
EBLON
EBS
EE.
EMOBN
F5P
FEDTE
FYUFA
GROUPED_DOAJ
HCIFZ
HMCUK
HVGLF
HYE
HZ~
KQ8
LK8
M1P
M48
M7P
M~E
NAO
O9-
OK1
P2P
P62
PIMPY
PQQKQ
PROAC
PSQYO
RNS
RNT
RNTTT
RPM
SNYQT
SV3
TSG
UKHRP
AASML
AAYXX
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7T7
7TM
7TO
7XB
8FD
8FK
AARCD
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
RC3
SOI
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c584t-55eb5f6416d3f69edf908cc4324419e43a4799fa8b567cd0d4c19449b4372a013
IEDL.DBID 8FG
ISSN 2041-1723
IngestDate Wed Aug 27 01:08:53 EDT 2025
Thu Aug 21 13:52:07 EDT 2025
Fri Sep 05 10:46:52 EDT 2025
Wed Aug 13 11:00:59 EDT 2025
Wed Feb 19 02:36:06 EST 2025
Thu Apr 24 22:50:28 EDT 2025
Tue Jul 01 02:21:05 EDT 2025
Fri Feb 21 02:39:47 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c584t-55eb5f6416d3f69edf908cc4324419e43a4799fa8b567cd0d4c19449b4372a013
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-0530-1326
OpenAccessLink https://www.proquest.com/docview/1952162794?pq-origsite=%requestingapplication%
PMID 29042554
PQID 1952162794
PQPubID 546298
PageCount 9
ParticipantIDs doaj_primary_oai_doaj_org_article_0fc143dfc7464c2e803e239b8d4ccb42
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5645389
proquest_miscellaneous_1952529624
proquest_journals_1952162794
pubmed_primary_29042554
crossref_primary_10_1038_s41467_017_00952_3
crossref_citationtrail_10_1038_s41467_017_00952_3
springer_journals_10_1038_s41467_017_00952_3
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-10-17
PublicationDateYYYYMMDD 2017-10-17
PublicationDate_xml – month: 10
  year: 2017
  text: 2017-10-17
  day: 17
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Nature communications
PublicationTitleAbbrev Nat Commun
PublicationTitleAlternate Nat Commun
PublicationYear 2017
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References Gerhart, LeVasseur, Broderius, Drewes (CR30) 1989; 22
Mammen, Choi, Whitesides (CR24) 1998; 37
Matsumoto (CR28) 2010; 1
Xie (CR20) 2012; 7
Petros, DeSimone (CR5) 2010; 9
Nishiyama (CR9) 2003; 63
Marchi, Granata, Ghosh, Janigro (CR36) 2012; 53
Mitragotri, Burke, Langer (CR4) 2014; 13
Cabral, Kataoka (CR14) 2014; 190
Yoo, Mitragotri (CR2) 2010; 107
Cabral (CR1) 2011; 6
Riskin, Nannegari, Mond (CR32) 2008; 63
Plummer (CR12) 2011; 104
Qin (CR21) 2010; 18
Jiang (CR37) 2014; 35
Grant, Donaldson (CR33) 2009; 10
Duncan (CR10) 2003; 2
Underhill, Toole (CR23) 1980; 255
Simpson (CR27) 1999; 72
Hamaguchi (CR13) 2007; 97
Ferrari (CR7) 2005; 5
Alexis, Pavel, Felipe, Juan, Jorge (CR25) 2004; 87
Leto, Saltiel (CR34) 2012; 13
Zensi (CR18) 2009; 137
Oldendorf, Crane, Lawner, Braun (CR38) 1983; 14
Napoli (CR6) 2004; 3
Foley, Boguslavsky, Klip (CR35) 2011; 50
Geng (CR3) 2007; 2
Matsumura, Maeda (CR8) 1986; 46
CR22
Wiley, Webster, Gale, Davis (CR17) 2013; 110
Abbott, Patabendige, Dolman, Yusof, Begley (CR15) 2010; 37
Banks (CR16) 2016; 15
Uchida (CR19) 2011; 117
Muoio, Persson, Sendeski (CR29) 2014; 210
Barnett, Holman, Munday (CR26) 1973; 131
Eyster (CR31) 2009; 10
Kim, Rutka, Chan (CR11) 2010; 363
SB Alexis (952_CR25) 2004; 87
952_CR22
Y Geng (952_CR3) 2007; 2
Y Uchida (952_CR19) 2011; 117
D Leto (952_CR34) 2012; 13
CA Eyster (952_CR31) 2009; 10
A Zensi (952_CR18) 2009; 137
DZ Gerhart (952_CR30) 1989; 22
Y Matsumoto (952_CR28) 2010; 1
RA Petros (952_CR5) 2010; 9
R Plummer (952_CR12) 2011; 104
IA Simpson (952_CR27) 1999; 72
S Mitragotri (952_CR4) 2014; 13
N Nishiyama (952_CR9) 2003; 63
R Duncan (952_CR10) 2003; 2
N Marchi (952_CR36) 2012; 53
T Hamaguchi (952_CR13) 2007; 97
JW Yoo (952_CR2) 2010; 107
NJ Abbott (952_CR15) 2010; 37
WA Banks (952_CR16) 2016; 15
BY Kim (952_CR11) 2010; 363
M Mammen (952_CR24) 1998; 37
F Xie (952_CR20) 2012; 7
A Napoli (952_CR6) 2004; 3
CB Underhill (952_CR23) 1980; 255
WH Oldendorf (952_CR38) 1983; 14
JEG Barnett (952_CR26) 1973; 131
M Ferrari (952_CR7) 2005; 5
H Cabral (952_CR1) 2011; 6
K Foley (952_CR35) 2011; 50
V Muoio (952_CR29) 2014; 210
Y Matsumura (952_CR8) 1986; 46
Y Qin (952_CR21) 2010; 18
DT Wiley (952_CR17) 2013; 110
X Jiang (952_CR37) 2014; 35
H Cabral (952_CR14) 2014; 190
BD Grant (952_CR33) 2009; 10
A Riskin (952_CR32) 2008; 63
References_xml – volume: 3
  start-page: 183
  year: 2004
  end-page: 189
  ident: CR6
  article-title: Oxidation-responsive polymeric vesicles
  publication-title: Nat. Mater.
  doi: 10.1038/nmat1081
– ident: CR22
– volume: 7
  start-page: 163
  year: 2012
  end-page: 175
  ident: CR20
  article-title: Investigation of glucose-modified liposomes using polyethylene glycols with different chain lengths as the linkers for brain targeting
  publication-title: Int. J. Nanomed.
  doi: 10.2147/IJN.S23771
– volume: 210
  start-page: 790
  year: 2014
  end-page: 798
  ident: CR29
  article-title: The neurovascular unit – concept review
  publication-title: Acta Physiol.
  doi: 10.1111/apha.12250
– volume: 131
  start-page: 211
  year: 1973
  end-page: 221
  ident: CR26
  article-title: Structural requirements for binding to the sugar-transport system of the human erythrocyte
  publication-title: Biochem. J.
  doi: 10.1042/bj1310211
– volume: 1
  start-page: 1209
  year: 2010
  end-page: 1216
  ident: CR28
  article-title: Direct and instantaneous observation of intravenously injected substances using intravital confocal micro-videography
  publication-title: Biomed. Opt. Express
  doi: 10.1364/BOE.1.001209
– volume: 2
  start-page: 347
  year: 2003
  end-page: 360
  ident: CR10
  article-title: The dawning era of polymer therapeutics
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd1088
– volume: 10
  start-page: 590
  year: 2009
  end-page: 599
  ident: CR31
  article-title: Discovery of new cargo proteins that enter cells through clathrin-independent endocytosis
  publication-title: Traffic
  doi: 10.1111/j.1600-0854.2009.00894.x
– volume: 6
  start-page: 815
  year: 2011
  end-page: 823
  ident: CR1
  article-title: Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
  publication-title: Nat. Nanotechnol
  doi: 10.1038/nnano.2011.166
– volume: 46
  start-page: 6387
  year: 1986
  end-page: 6392
  ident: CR8
  article-title: A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs
  publication-title: Cancer Res.
– volume: 37
  start-page: 2754
  year: 1998
  end-page: 2794
  ident: CR24
  article-title: Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors
  publication-title: Angew. Chem. Int. Ed.
  doi: 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3
– volume: 10
  start-page: 597
  year: 2009
  end-page: 608
  ident: CR33
  article-title: Pathways and mechanisms of endocytic recycling
  publication-title: Nat. Rev. Mol. Cell. Biol.
  doi: 10.1038/nrm2755
– volume: 53
  start-page: 1877
  year: 2012
  end-page: 1886
  ident: CR36
  article-title: Blood-brain barrier dysfunction and epilepsy: pathophysiologic role and therapeutic approaches
  publication-title: Epilepsia
  doi: 10.1111/j.1528-1167.2012.03637.x
– volume: 37
  start-page: 13
  year: 2010
  end-page: 25
  ident: CR15
  article-title: Structure and function of the blood–brain barrier
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2009.07.030
– volume: 50
  start-page: 3048
  year: 2011
  end-page: 3061
  ident: CR35
  article-title: Endocytosis, recycling, and regulated exocytosis of glucose transporter 4
  publication-title: Biochemistry
  doi: 10.1021/bi2000356
– volume: 35
  start-page: 518
  year: 2014
  end-page: 529
  ident: CR37
  article-title: Nanoparticles of 2-deoxy-D-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2013.09.094
– volume: 363
  start-page: 2434
  year: 2010
  end-page: 2443
  ident: CR11
  article-title: Nanomedicine
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMra0912273
– volume: 87
  start-page: 2990
  year: 2004
  end-page: 2999
  ident: CR25
  article-title: Predicting the three-dimensional structure of the human facilitative glucose transporter glut1 by a novel evolutionary homology strategy: Insights on the molecular mechanism of substrate migration, and binding sites for glucose and inhibitory molecules
  publication-title: Biophys. J.
  doi: 10.1529/biophysj.104.047886
– volume: 107
  start-page: 11205
  year: 2010
  end-page: 11210
  ident: CR2
  article-title: Polymer particles that switch shape in response to a stimulus
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1000346107
– volume: 63
  start-page: 8977
  year: 2003
  end-page: 8983
  ident: CR9
  article-title: Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice
  publication-title: Cancer Res.
– volume: 72
  start-page: 238
  year: 1999
  end-page: 247
  ident: CR27
  article-title: Blood–brain barrier glucose transporter: Effects of hypo- and hyperglycemia revisited
  publication-title: J. Neurochem.
  doi: 10.1046/j.1471-4159.1999.0720238.x
– volume: 190
  start-page: 465
  year: 2014
  end-page: 476
  ident: CR14
  article-title: Progress of drug-loaded polymeric micelles into clinical studies
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2014.06.042
– volume: 9
  start-page: 615
  year: 2010
  end-page: 627
  ident: CR5
  article-title: Strategies in the design of nanoparticles for therapeutic applications
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd2591
– volume: 15
  start-page: 275
  year: 2016
  end-page: 292
  ident: CR16
  article-title: From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery
  publication-title: Nat. Rev. Drug. Discov.
  doi: 10.1038/nrd.2015.21
– volume: 13
  start-page: 383
  year: 2012
  end-page: 396
  ident: CR34
  article-title: Regulation of glucose transport by insulin: traffic control of GLUT4
  publication-title: Nat. Rev. Mol. Cell. Biol.
  doi: 10.1038/nrm3351
– volume: 5
  start-page: 161
  year: 2005
  end-page: 171
  ident: CR7
  article-title: Cancer nanotechnology: opportunities and challenges
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc1566
– volume: 104
  start-page: 593
  year: 2011
  end-page: 598
  ident: CR12
  article-title: A phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours
  publication-title: Br. J. Cancer
  doi: 10.1038/bjc.2011.6
– volume: 117
  start-page: 333
  year: 2011
  end-page: 345
  ident: CR19
  article-title: Quantitative targeted absolute proteomics of human blood–brain barrier transporters and receptors
  publication-title: J. Neurochem.
  doi: 10.1111/j.1471-4159.2011.07208.x
– volume: 63
  start-page: 56
  year: 2008
  end-page: 61
  ident: CR32
  article-title: Acute effectors of GLUT1 glucose transporter subcellular targeting in CIT mouse mammary epithelial cells
  publication-title: Pediatr. Res.
  doi: 10.1203/PDR.0b013e31815b440b
– volume: 97
  start-page: 170
  year: 2007
  end-page: 176
  ident: CR13
  article-title: A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation
  publication-title: Br. J. Cancer
  doi: 10.1038/sj.bjc.6603855
– volume: 110
  start-page: 8662
  year: 2013
  end-page: 8667
  ident: CR17
  article-title: Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1307152110
– volume: 18
  start-page: 536
  year: 2010
  end-page: 549
  ident: CR21
  article-title: and investigation of glucose-mediated brain-targeting liposomes
  publication-title: J. Drug Target.
  doi: 10.3109/10611861003587235
– volume: 13
  start-page: 655
  year: 2014
  end-page: 672
  ident: CR4
  article-title: Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd4363
– volume: 14
  start-page: 388
  year: 1983
  end-page: 393
  ident: CR38
  article-title: Rapid, transient drop in brain glucose after intravenous phloretin or 3-O-methyl-D-glucose
  publication-title: Stroke
  doi: 10.1161/01.STR.14.3.388
– volume: 2
  start-page: 249
  year: 2007
  end-page: 255
  ident: CR3
  article-title: Shape effects of filaments versus spherical particles in flow and drug delivery
  publication-title: Nat. Nanotechnol
  doi: 10.1038/nnano.2007.70
– volume: 22
  start-page: 464
  year: 1989
  end-page: 472
  ident: CR30
  article-title: Glucose transporter localization in brain using light and electron immunocytochemistry
  publication-title: J. Neurosci. Res.
  doi: 10.1002/jnr.490220413
– volume: 137
  start-page: 78
  year: 2009
  end-page: 86
  ident: CR18
  article-title: Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2009.03.002
– volume: 255
  start-page: 4544
  year: 1980
  end-page: 4549
  ident: CR23
  article-title: Physical characteristics of hyaluronate binding to the surface of simian virus 40-transformed 3T3 cells
  publication-title: J. Biol. Chem.
– volume: 18
  start-page: 536
  year: 2010
  ident: 952_CR21
  publication-title: J. Drug Target.
  doi: 10.3109/10611861003587235
– volume: 37
  start-page: 2754
  year: 1998
  ident: 952_CR24
  publication-title: Angew. Chem. Int. Ed.
  doi: 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3
– volume: 131
  start-page: 211
  year: 1973
  ident: 952_CR26
  publication-title: Biochem. J.
  doi: 10.1042/bj1310211
– volume: 72
  start-page: 238
  year: 1999
  ident: 952_CR27
  publication-title: J. Neurochem.
  doi: 10.1046/j.1471-4159.1999.0720238.x
– volume: 10
  start-page: 597
  year: 2009
  ident: 952_CR33
  publication-title: Nat. Rev. Mol. Cell. Biol.
  doi: 10.1038/nrm2755
– volume: 104
  start-page: 593
  year: 2011
  ident: 952_CR12
  publication-title: Br. J. Cancer
  doi: 10.1038/bjc.2011.6
– volume: 2
  start-page: 347
  year: 2003
  ident: 952_CR10
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd1088
– volume: 2
  start-page: 249
  year: 2007
  ident: 952_CR3
  publication-title: Nat. Nanotechnol
  doi: 10.1038/nnano.2007.70
– volume: 97
  start-page: 170
  year: 2007
  ident: 952_CR13
  publication-title: Br. J. Cancer
  doi: 10.1038/sj.bjc.6603855
– volume: 255
  start-page: 4544
  year: 1980
  ident: 952_CR23
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(19)85527-8
– volume: 190
  start-page: 465
  year: 2014
  ident: 952_CR14
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2014.06.042
– volume: 137
  start-page: 78
  year: 2009
  ident: 952_CR18
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2009.03.002
– volume: 5
  start-page: 161
  year: 2005
  ident: 952_CR7
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc1566
– volume: 53
  start-page: 1877
  year: 2012
  ident: 952_CR36
  publication-title: Epilepsia
  doi: 10.1111/j.1528-1167.2012.03637.x
– volume: 13
  start-page: 383
  year: 2012
  ident: 952_CR34
  publication-title: Nat. Rev. Mol. Cell. Biol.
  doi: 10.1038/nrm3351
– volume: 87
  start-page: 2990
  year: 2004
  ident: 952_CR25
  publication-title: Biophys. J.
  doi: 10.1529/biophysj.104.047886
– volume: 9
  start-page: 615
  year: 2010
  ident: 952_CR5
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd2591
– volume: 63
  start-page: 56
  year: 2008
  ident: 952_CR32
  publication-title: Pediatr. Res.
  doi: 10.1203/PDR.0b013e31815b440b
– volume: 37
  start-page: 13
  year: 2010
  ident: 952_CR15
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2009.07.030
– volume: 10
  start-page: 590
  year: 2009
  ident: 952_CR31
  publication-title: Traffic
  doi: 10.1111/j.1600-0854.2009.00894.x
– volume: 7
  start-page: 163
  year: 2012
  ident: 952_CR20
  publication-title: Int. J. Nanomed.
  doi: 10.2147/IJN.S23771
– volume: 1
  start-page: 1209
  year: 2010
  ident: 952_CR28
  publication-title: Biomed. Opt. Express
  doi: 10.1364/BOE.1.001209
– volume: 22
  start-page: 464
  year: 1989
  ident: 952_CR30
  publication-title: J. Neurosci. Res.
  doi: 10.1002/jnr.490220413
– volume: 15
  start-page: 275
  year: 2016
  ident: 952_CR16
  publication-title: Nat. Rev. Drug. Discov.
  doi: 10.1038/nrd.2015.21
– volume: 210
  start-page: 790
  year: 2014
  ident: 952_CR29
  publication-title: Acta Physiol.
  doi: 10.1111/apha.12250
– ident: 952_CR22
– volume: 363
  start-page: 2434
  year: 2010
  ident: 952_CR11
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMra0912273
– volume: 117
  start-page: 333
  year: 2011
  ident: 952_CR19
  publication-title: J. Neurochem.
  doi: 10.1111/j.1471-4159.2011.07208.x
– volume: 35
  start-page: 518
  year: 2014
  ident: 952_CR37
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2013.09.094
– volume: 6
  start-page: 815
  year: 2011
  ident: 952_CR1
  publication-title: Nat. Nanotechnol
  doi: 10.1038/nnano.2011.166
– volume: 63
  start-page: 8977
  year: 2003
  ident: 952_CR9
  publication-title: Cancer Res.
– volume: 14
  start-page: 388
  year: 1983
  ident: 952_CR38
  publication-title: Stroke
  doi: 10.1161/01.STR.14.3.388
– volume: 3
  start-page: 183
  year: 2004
  ident: 952_CR6
  publication-title: Nat. Mater.
  doi: 10.1038/nmat1081
– volume: 50
  start-page: 3048
  year: 2011
  ident: 952_CR35
  publication-title: Biochemistry
  doi: 10.1021/bi2000356
– volume: 13
  start-page: 655
  year: 2014
  ident: 952_CR4
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd4363
– volume: 46
  start-page: 6387
  year: 1986
  ident: 952_CR8
  publication-title: Cancer Res.
– volume: 107
  start-page: 11205
  year: 2010
  ident: 952_CR2
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1000346107
– volume: 110
  start-page: 8662
  year: 2013
  ident: 952_CR17
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1307152110
SSID ssj0000391844
Score 2.625088
Snippet Recently, nanocarriers that transport bioactive substances to a target site in the body have attracted considerable attention and undergone rapid progression...
There are only a few examples of nanocarriers that can transport bioactive substances across the blood-brain barrier. Here the authors show that by rapid...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1001
SubjectTerms 631/378/1341
631/61/350/2093
639/925/352/152
Accumulation
Animals
Biological activity
Blood Glucose - metabolism
Blood-brain barrier
Blood-Brain Barrier - metabolism
Brain - blood supply
Brain - metabolism
Cell migration
Drug Carriers - metabolism
Drug Carriers - pharmacokinetics
Endothelial cells
Female
Glucose
Glucose - metabolism
Glucose transporter
Glucose Transporter Type 1 - metabolism
Glycosylation
Humanities and Social Sciences
Humans
Mice, Inbred BALB C
Micelles
Microscopy, Confocal
multidisciplinary
Nanoparticles - metabolism
Neurons
Neurons - metabolism
Polymers - chemistry
Polymers - metabolism
Science
Science (multidisciplinary)
Transport
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LaxsxEBYhUMil9JG226ZFgdzaJdJK2pWOdWkaCgkEGshNaPWgAbMO8ebgf98ZaW3sPi892tLaw7fz-MSMZgg5YZ1zwPL7Wim8kqO6WGuvVa2dTCG1EHA53h2-uGzPr-XXG3WzNeoLa8JKe-AC3ClLHkJ6SL6TrfRN1EzERpheB-l9L7P3ZYZtHaayDxYGji5yuiXDhD5dyuwT0CkjrWhqsROJcsP-37HMX4slf8qY5kB09oQ8nhgk_Vgkf0r24vCMPCozJVfPydWX-co7LHmnUxk6BSK9HJe0VKev5sAuAx3cAFHsHufV0Swf_BcFMkhnsxm9HcZF_tDjAIlDcn32-dun83qam1B7oBMjwB57lVqgWkGk1sSQDNPeY-89yU2UwsnOmOR0r9rOBwZIciOl6TGH54ATviD7w2KIrwgFi4-MpwSnQCalcppLOGCYNonQpKB4RfgaQ-unpuI422Juc3JbaFtwt4C7zbhbUZH3m2fuSkuNv-6e4avZ7MR22PkLUBI7KYn9l5JU5Gj9Yu1ko0vL4fd524BDqsjxZhmsC1MmboiLh7IHM9MN7HlZ9GAjSWPQ4SlY6XY0ZEfU3ZXh9nvu4I0tfIApVuTDWpe2xPojFK__BxRvyEGDRoBFOd0R2R_vH-Jb4FVj_y6b0A_QWRv3
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA_nieCL-G31lAi-abX5bPIg4ornIZwguHBvIU2T82Dp6m4P3P_embRdXF3vsU3appP5-A0zmSHkRVV7Dyi_KZXCIzmqjqUJRpXGy9QmDQaX4dnh0y_6ZC4_n6mzAzK1OxoJuN7r2mE_qflq8frXz807EPi3w5Fx82Yts7ijvkXEwEtxjVwHy6TRGTsd4X7WzMKCQyPHszP7H92xT7mM_z7s-W8K5V9x1Gyejm-TWyOupO8HRrhDDmJ3l9wYOk1u7pGvnxab4DERno7J6RTg9bpf0yFnfbMAzNnSzndg21bYxY7m9cG3KEBEOpvN6EXXL_NFg20l7pP58cdvH07KsZtCGQBk9LAZsVFJA1lakbSNbbKVCQEr8klmoxRe1tYmbxql69BWrQzMSmkbjOx5QIoPyGG37OIjQkEPxIqlBL5hJaXyhklwO6xOouWpVawgbKKhC2Opcex4sXA55C2MG-jugO4u092JgrzcPvNjKLRx5ewZbs12JhbJzjeWq3M3ypyrUgA02KZQSy0Dj6YSkQvbGPi10EhekKNpY93EeI7B-5nmoKYK8nw7DDKHgRTfxeXlMAfj1RzmPBz4YLsSblENKhipdzhkZ6m7I93F91zXGwv7AH4syKuJl_5Y1n9J8fjqv3hCbnJkb0zCqY_IYb-6jE8BR_XNsywcvwEjwBZB
  priority: 102
  providerName: Scholars Portal
– databaseName: Springer Nature Link OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3daxQxEA-1Ivgi1s_VViL4pou7-drk0Ttai6AgWOhbyOZDC8ee3G0f7r93JvuBp1Xo421m9-ZmZ5Jfbia_IeRN1TgHKL8tpcQjObKJpfZaltqJFJKCBbfGs8Ofv6jzC_HpUl4eEDadhclF-5nSMk_TU3XY-63IIY1zKqICVvI75K6GfR169VIt5_9VkPFcCzGej6m4vuHWvTUoU_XfhC__LpP8I1eal6Czh-TBiB3ph0HbI3IQu0fk3tBNcveYfP242nmHxe50LECnAKG3_ZYOdem7FeDKQDvXwfq1wU51NOsH30UBBtLFYkGvun6dP7TYOuIJuTg7_bY8L8eOCaUHINGDwWMrkwKQFXhSJoZkKu09su6J2kTBnWiMSU63UjU-VEH42ghhWszeOUCDT8lht-7ic0Ih1mNVpwT7v0oI6XQtYGthVOKBpSDrgtSTDa0f6cSxq8XK5rQ213awuwW722x3ywvydr7n50Cm8V_pBb6aWRKJsPOF9ea7HR3DVskD4gvJN0IJz6KueGTctBp-mm8FK8jx9GLtGJ1bW8Pza8VgKirI63kY4gqTJa6L6-tBBnPSDGSeDX4wa8IMTnUSRpo9D9lTdX-ku_qRubuRvAcwYkHeTb70m1r_NMWL24m_JPcZujsW3jTH5LDfXMcTwE59-yoHyy-cBhDR
  priority: 102
  providerName: Springer Nature
Title Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain
URI https://link.springer.com/article/10.1038/s41467-017-00952-3
https://www.ncbi.nlm.nih.gov/pubmed/29042554
https://www.proquest.com/docview/1952162794
https://www.proquest.com/docview/1952529624
https://pubmed.ncbi.nlm.nih.gov/PMC5645389
https://doaj.org/article/0fc143dfc7464c2e803e239b8d4ccb42
Volume 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb5wwELaaRJV6qfouabpypd5aFB422KdqWWUTrZSor0h7Q8bYaaQVpAs57L_PjPHSbh-5gMBGmPE8PjzjGULeR7lSgPKrkHPcksNzEwoteCgUs7XNwODGuHf4_CI7u2SLJV_6BbfOh1VudaJT1HWrcY38OJZgaLIE2OfTzc8Qq0ahd9WX0NgjBzFYGuRzMT8d11gw-7lgzO-ViVJx3DGnGVA1I7hIwnTHHrm0_f_Cmn-HTP7hN3XmaP6EPPY4kk6HiX9KHpjmGXk4VJbcPCdfTlcbrTDwnfpgdApwuus7OsSob1aAMWvaqAZs2Rqr1lE3PngXBUhIi6Kg103fuosKy0i8IJfzk--zs9BXTwg1gIoeiG8qbjMAXHVqM2lqKyOhNWbgY7E0LFUsl9IqUfEs13VUMx1LxmSFnjwFyPAl2W_axrwmFOTeRLG18C8YMcaViBn8ZsjMpnViax4HJN7SsNQ-tThWuFiVzsWdinKgewl0Lx3dyzQgH8ZnbobEGvf2LnBqxp6YFNvdaNdXpZexMrIa0F9tdc4yphMjotQkqawEfJquWBKQo-3Ell5Su_IXXwXk3dgMMoaOE9WY9nbog_7pBPq8GvhgHEkiUe1xaMl3OGRnqLstzfUPl8cbE_kAXgzIxy0v_Tas_5Li8P6veEMeJcjeGHSTH5H9fn1r3gJu6qsJ2cuX-cSJyIQcTKeLbws4FycXn7_C3Vk2m7gVCTieM3EH8e4Zyg
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9QwELZKEYIXxE2ggJHgCaImjpPYDwixQNnSQ0JqpX0zjg-otMqWTSq0f4rfyIxzwHL0rY-7dnYn4zk-e8YzhDxLSq0B5VdxnuOVnLx0sTAij4Xm3voCHG6Kd4cPDovpMf84y2cb5MdwFwbTKgebGAy1XRg8I99OJTiagoH4vD79FmPXKIyuDi00OrHYc6vvsGVrXu2-g_V9ztjO-6O307jvKhAbcLYtEOWq3BcARGzmC-msl4kwBivT8VQ6nmleSum1qPKiNDax3MBGn8sKI1waEBP87iVymePJOOhPOSvHMx2sti447-_mJJnYbniwROgKEMywOFvzf6FNwL-w7d8pmn_EaYP727lBrve4lb7pBO0m2XD1LXKl62S5uk0-fZivjMZEe9onv1OA703b0C4nfjUHTGtprWvwnUvskkcDffBfFCAonUwm9KRuF-FDhW0r7pDjC-HrXbJZL2p3n1CwMy5JvYe9Z8J5rkXKYVsjC59Z5m2eRiQdeKhMX8ocO2rMVQipZ0J1fFfAdxX4rrKIvBifOe0KeZw7e4JLM87EItzhi8Xyi-p1WiXeANq03pS84IY5kWSOZbIS8Gqm4iwiW8PCqt4yNOqXHEfk6TgMOo2BGl27xVk3B-PhDObc6-RgpIRJNLM5jJRrErJG6vpIffI11A3HwkGATyPycpCl38j6LysenP8WT8jV6dHBvtrfPdx7SK4xFHVM-Cm3yGa7PHOPALO11eOgKJR8vmjN_AnUvE7C
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKEYgL4k2ggJHgBNEmtpPYB4RYyralUIFEpd5M4gdUWiVlkwrtX-PXMeMkC8ujtx43drKT8Xjmm8x4hpAnSVGWgPKrOMvwSE5WuFgamcWyFN76HAxuimeH3x_ku4fi7VF2tEF-jGdhMK1y1IlBUdvG4DfySarA0OQMxGfih7SID9uzlyffYuwghZHWsZ1GLyL7bvkd3Lf2xd42rPVTxmZvPr3ejYcOA7EBw9sBga7KfA6gxHKfK2e9SqQxWKVOpMoJXopCKV_KKssLYxMrDDj9QlUY7SoBPcFzL5CLBS8UOn5ytrP6voOV16UQwzmdhMtJK4JWQrOAwIbFfM0WhpYB_8K5f6dr_hGzDaZwdo1cHTAsfdUL3XWy4eob5FLf1XJ5k3zcmS9NiUn3dEiEpwDl266lfX78cg741tK6rMGOLrBjHg30wX9RgKN0Op3S47prwo8KW1jcIofnwtfbZLNuaneXUNA5Lkm9Bz80ESIrZSrAxVG555Z5m6URSUceajOUNcfuGnMdwutc6p7vGviuA981j8iz1T0nfVGPM2dPcWlWM7Egd7jQLL7oYX_rxBtAntabQuTCMCcT7hhXlYRXM5VgEdkaF1YPWqLVv2Q6Io9Xw7C_MWhT1q457edgbJzBnDu9HKwoYQpVbgYjxZqErJG6PlIffw01xLGIEGDViDwfZek3sv7Lintnv8Ujchn2pH63d7B_n1xhKOmY-1Nskc1uceoeAHzrqodhn1Dy-bw35k_pslMK
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Glycaemic+control+boosts+glucosylated+nanocarrier+crossing+the+BBB+into+the+brain&rft.jtitle=Nature+communications&rft.au=Anraku%2C+Y&rft.au=Kuwahara%2C+H&rft.au=Fukusato%2C+Y&rft.au=Mizoguchi%2C+A&rft.date=2017-10-17&rft.pub=Nature+Publishing+Group&rft.eissn=2041-1723&rft.volume=8&rft.spage=1&rft.epage=9&rft_id=info:doi/10.1038%2Fs41467-017-00952-3&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon